http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-019031-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ef8acc27b4252e343aa5da877c870d2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-536
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-536
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
filingDate 1999-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2001-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-019031-A1
titleOfInvention PHARMACEUTICAL FORM OF DOSAGE OF EFAVIRENZ IN CAPSULA OR COMPRESSED TABLET AND METHOD FOR PREPARATION
abstract This provides formulations of improved oral dosage forms of efavirenz that are useful in the inhibition of human immunodeficiency virus (HIV), in the prevention or treatment of an HIV infection and in the treatment of acquired immunodeficiency syndrome (AIDS) resulting. In particular, this relates to compressed tablets or capsules comprising efavirenz that contain one or more disintegrators that improve the dissolution rate of efavirenz in the gastrointestinal tract thereby improving the speed and degree of absorption of efavirenz in the body. This also relates to the process for making said tablets or capsules.
priorityDate 1998-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64139

Total number of triples: 23.